Skip to content
Winfred
Back to Investors
GI

Gabriel Investment

Angel

Portfolio

2

companies

By category

  • BioTech£4.2M
  • AgriTech£500K

By location

  • Edinburgh£4.7M

Portfolio companies

C

Carcinotech

Carcinotech uses 3D bioprinting technology to simulate tumour microenvironments for cancer research.

D

Dyneval

Dyneval builds portable instruments for semen analysis to improve farming efficiency.

Recent investments

£4.2M

Carcinotech raises £4.2m from Eos Advisory and Maven Capital Partners to expand internationally

BioTech

The Edinburgh biotech uses the capital to scale its 3D bioprinted tumour models across the UK, Europe, and the US.

"Our vision is to be at the forefront of cancer drug testing and provide personalised medicine testing to every individual suffering from cancer to improve their treatment and chance of survival. Working with global partners, leading pharma companies, surgeons, pathologists, and clinicians, Carcinotech aims to accelerate oncology drug development significantly."
— Ishani Malhotra, CEO and Founder
C
Carcinotech— Edinburgh, UK
Eos Advisory
Maven
Scottish Enterprise
Eos Advisory + 8 others
£500K

Dyneval secures £500k from Kelvin Capital and other backers to scale semen analyser production.

AgriTechBioTech

The Edinburgh based agritech firm has raised over half a million pounds to accelerate manufacturing of its portable semen testing device.

"We are very proud to secure this additional round of funding which will help to rapidly increase our production meaning we can help even more farmers across Scotland, the UK and beyond."
— Tiffany Wood, Co-founder
D
Dyneval— Edinburgh, UK
Kelvin Capital
Scottish Enterprise
GI
Kelvin Capital + 3 others